Recent studies have revealed the unique function of the IRG1/itaconate axis in modulating inflammation and demonstrated the anti-inflammatory effects of itaconate on suppressing succinate dehydrogenase (SDH) activity, activating the Nrf2/HO-1 pathway and ameliorating disease severity in several animal disease models.8 The gene discussed is NFE2L2; the disease is non-human animal disease.